WEI LIN (Chief Medical Officer) received a stock award from REVOLUTION MEDICINES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001610717-26-000084
Officer· Chief Medical Officer
Since Mar 2026
+49.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
49.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.10K
Price / share
—
Trade value
—
% of position
17.1%
3/1/2026
88.34K→103.44K
Total
Net shares
+15.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +15.10K | — | — | 17.1% | 88.34K | 103.44K |
| Total | +15.10K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
34K shares
Shares
+34K
Strike price
102.02
Held after
34K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock34K shares | 3/1/2026 | A · Award | +34K | 102.02 | — | 34K |